| Bid Price | 7.50p | High Price | 7.53p |
|---|
| Ask Price | 8.00p | Low Price | 7.15p |
|---|
| Open Price | 7.75p | Spread | 6.25% |
|---|
| Prev Close | 7.75p | Volume | 643,791 |
|---|
Renalytix PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Nov 22, 2024 | 7.75 | 7.53 | 7.15 | 7.75 | 643,791 |
| Nov 21, 2024 | 7.75 | 8.00 | 7.20 | 7.75 | 194,880 |
| Nov 20, 2024 | 7.75 | 8.00 | 7.50 | 7.75 | 147,902 |
| Nov 19, 2024 | 7.75 | 7.53 | 7.50 | 7.75 | 57,297 |
| Nov 18, 2024 | 7.75 | 8.00 | 7.50 | 7.75 | 22,805 |
Renalytix PLC Information
| Name | Renalytix PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BYWL4Y04 | Epic | RENX |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASX1 |
|---|
| Industry | Health Information Services | Sector | Healthcare |
|---|
| EMS | 3,000 | Trading Status | Closed |
|---|
| Shares in Issue | 333.64 m | Prev Close | 7.75p |
|---|
| PE Ratio | | Market Cap | £25.86 m |
|---|
| Div Yield | 0 | Div per Share | $NaN |
|---|
| EPS | -$0.04 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.239657 | Quick Ratio | 0.150753 |
|---|
Renalytix PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 11/10/24 | BUY | Christopher Mills | NED | 500,000 @ £0.09 | £45,000.00 |
| 11/10/24 | SELL | Christopher Mills | NED | 83,696 @ £0.08 | £6,696.00 |
| 09/10/24 | PLAC | Christopher Mills | NED | 500,000 @ £0.09 | £45,000.00 |
| 09/10/24 | PLAC | James McCullough | CEO | 417,710 @ £0.09 | £37,594.00 |
| 09/10/24 | PLAC | Fergus Fleming | ED | 83,542 @ £0.09 | £7,519.00 |
| 09/10/24 | PLAC | Catherine Coste | D | 279,866 @ £0.09 | £25,188.00 |
| 18/03/24 | PLAC | Christopher Mills | NED | 4,000,000 @ £0.20 | £800,000.00 |
| 10/02/23 | PLAC | Christopher Mills | NED | 346,375 @ £0.90 | £311,738.00 |
| 07/04/22 | PLAC | Ann Berman | RES | 27,586 @ $2.76 | $76,137.00 |
| 07/04/22 | PLAC | Timothy Scannell | RES | 68,964 @ £2.76 | £190,341.00 |
Renalytix PLC News
